SHORT FACTOR CERTIFICATE - PFIZER INC | Real-time Euronext Paris 11:13:21 03/06/2024 BST | ||
| 0.5 EUR | -7.41% |
|
| 1 month | -93.70% | ||
| 3 months | -96.48% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 03/06/24 | 0.5 | -7.41% |
| 31/05/24 | 0.54 | -28.95% |
| 30/05/24 | 0.76 | -7.32% |
| 29/05/24 | 0.82 | +26.15% |
| 28/05/24 | 0.65 | +38.30% |
Real-time Euronext Paris
Last update June 03, 2024 at 11:13 am
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | PUT |
| Underlying | PFIZER, INC. |
| Issuer | Goldman Sachs |
| 9V6ZH | |
| ISIN | DE000GZ4RTC4 |
| Date issued | 05/12/2022 |
| Strike | 30.09 $ |
| Maturity | Unlimited |
| Parity | 2.71 : 1 |
| Emission price | 9.05 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 124.2 € |
|---|---|
| Lowest since issue | 0.34 € |
| Spread | 0.03 € |
| Spread % | 6.12% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.66
USD
Average target price
31.92
USD
Spread / Average Target
+11.36%
- Stock Market
- Certificates
- 9V6ZH Certificat
